Adam S. Grossman, President and CEO at ADMA BIOLOGICS, INC. (ADMA), bought 4,000 shares at $2.24 ($9K) on 2020-09-08, disclosed to the SEC on 2020-09-10.
Open-market purchase of $9k ADMA by President and CEO. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Nothing distinguishes this filing.
| Filing → |
| ADMA | SELL | 2025-12-16 | $416K | — | Filing → |
| ADMA | SELL | 2025-11-21 | $336K | — | Filing → |
| ADMA | SELL | 2025-10-24 | $336K | — | Filing → |